North America Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The North America Blood Glucose Monitoring Market is segmented by Type (Self-monitoring Blood Glucose Devices (Glucometer Devices, Test Strips, and Lancets), Continuous Glucose Monitoring Devices (Sensors, and Durables)), and Geography.

Market Snapshot

Blood Glucose test Strips
Study Period:

2018 - 2026

Base Year:

2020

CAGR:

8.66 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Diabetes has emerged as a global epidemic and has afflicted millions of population, worldwide. While Type-1 diabetes is caused by an immune system malfunction, Type-2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type-1 diabetes can be characterized as insulin-requiring, while Type-2 diabetes can be characterized as insulin-dependent diabetes. The factors that have driven the number of reported cases of diabetes can be segmented into individual-level risk factors, environmental risk factors, the evolution of the disease, detection effect, and global changes. ​The rates of newly diagnosed cases of Type 1 and Type 2 diabetes in the US have witnessed a spike in recent years with nearly 40,000 new cases being registered each year alone for Type 1 diabetes.​ To enhance the quality of medical services and the effectiveness of the administered treatments, diabetes monitoring and prevention agencies such as the ADA is investing significant resources towards the R&D of new medical devices for controlling the outbreak and enhance the life expectancy of the diabetic patients.​ In 2018, the ADA funded 318 new and continuing projects targeting all types of diabetes and its many complications, across a broad spectrum of scientific approaches. ​Achieving nominal results can be very difficult without multiple daily injections of insulin or insulin pump therapy. This is driving the demand for diabetes care devices in North America, thereby, driving the market in focus during the forecast period.

Scope of the Report

The market size provided in the report has been derived from the revenue generated by product types. For estimating the market size of the product, the average selling price (ASP) of a product in the region was multiplied by the sales volume (new sales and replacement rate, based on applicability). The North American blood glucose monitoring market (henceforth referred to as ‘market studied’) is segmented based on type. Based on type, the market subject is segmented into Self-monitoring blood glucose monitoring and continuous glucose monitoring. The type segment is further categorized into self-monitoring blood glucose devices (test strips, glucometer devices, and lancets) and continuous glucose monitoring devices (sensors and durables). A holistic study of the market has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which are required to analyze future trends. Other countries in North America are covered under ‘Rest of North America’, for which market size and forecast value are provided.

Type
Self-monitoring Blood Glucose Devices
By Component (Value and Volume, 2012 - 2025)
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring
By Component (Value and Volume, 2012 - 2025)
Sensors
Durables
Geography
North America
United States (Value and Volume, 2012 - 2025)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Canada (Value and Volume, 2012 - 2025)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Rest of North America (Value and Volume, 2012 - 2025)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Blood Glucose Test Strips Segment Accounted for a Major Share in the Self-monitoring Blood Glucose Market

The growth of the market studied is expected to be spurred by the growing diabetic population in the North American region. The increase in the market volume and share of test strips is expected to be better than glucometers, due to the difference in the use-case frequency. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame, a corresponding use of multiple (in the range of thousands) test strips may occur, causing a recurrent cost impact. Home use of test strips is also increasing because of initiatives of provincial governments across Canada. The country implemented the blood glucose test strip (BGTS) quantity limits, to encourage proper testing practices for optimal patient outcomes. In Alberta, insulin-dependent patients are eligible for coverage of a USD 600 in a year, other regions also have reimbursement policies.

North America Blood Glucose Monitoring Market_trends1

To understand key trends, Download Sample Report

The United States Leads the Blood Glucose Monitoring Market

In 2019, the United States held the largest share in the blood glucose monitoring market, due to the large patient pool and broader acceptance of advanced technologies. The increase in the blood glucose monitoring market is due to the rise in the diabetes population in all age groups. The market value in the United States is expected to cross USD 10 billion by 2025. Diabetes-related complications are mostly due to poor glucose control. In the United States, the BGM Market is expected to record an approximate CAGR of 13% till 2025. Glucometers are now portable and accurate to use. Also, other factors, such as technological innovations and advances, give many conveniences in measuring blood glucose levels. One such advancement is in monitoring the blood glucose levels established with continuous glucose monitoring devices. In the United States, the new innovations from start-up companies having approximately 2.9 billion funding in diabetes industry like Glooko, OneDrop, verily, Vacate, Insulet, Noom, Bigfoot Biomedical, Virta Health, Diabeloop, Orgenesis, etc., these companies drive the United States Blood Glucose Monitoring Market.​

North America Blood Glucose Monitoring Market_Country

To understand geography trends, Download Sample Report

Competitive Landscape

The North American blood glucose monitoring market was dominated by a few major players in 2019, like Dexcom, Abbott, and Medtronic. In the United States, Dexcom holds more than 60% of the market in the year 2019. The innovations in devices are driving the market. For instance, in June 2018, the US Food and Drug Administration (FDA) approved the first implantable continuous glucose monitoring (CGM) device for people with Type 1 and Type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it’s approved for people aged 18 and above.​ Recently, Dario Health introduced a new glucometer device, which is more technologically advanced compared to the other glucometer present in the market. The device is very compact (pocket size) and accurate, and it gives the result in six seconds. This glucometer device has additional features, such as the measurement of other diabetes metrics, including carb counting, physical activity, and medication intake. The entrance of new players in the market will further increase the market competitiveness during the forecast period.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 Type

      1. 5.1.1 Self-monitoring Blood Glucose Devices

        1. 5.1.1.1 By Component (Value and Volume, 2012 - 2025)

          1. 5.1.1.1.1 Glucometer Devices

          2. 5.1.1.1.2 Test Strips

          3. 5.1.1.1.3 Lancets

      2. 5.1.2 Continuous Glucose Monitoring

        1. 5.1.2.1 By Component (Value and Volume, 2012 - 2025)

          1. 5.1.2.1.1 Sensors

          2. 5.1.2.1.2 Durables

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume, 2012 - 2025)

          1. 5.2.1.1.1 Self-monitoring Blood Glucose

            1. 5.2.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.1.2 Continuous Glucose Monitoring

            1. 5.2.1.1.2.1 By Component (Sensors and Durables)

        2. 5.2.1.2 Canada (Value and Volume, 2012 - 2025)

          1. 5.2.1.2.1 Self-monitoring Blood Glucose

            1. 5.2.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.2.2 Continuous Glucose Monitoring

            1. 5.2.1.2.2.1 By Component (Sensors and Durables)

        3. 5.2.1.3 Rest of North America (Value and Volume, 2012 - 2025)

          1. 5.2.1.3.1 Self-monitoring Blood Glucose

            1. 5.2.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.3.2 Continuous Glucose Monitoring

            1. 5.2.1.3.2.1 By Component (Sensors and Durables)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2025)

    2. 6.2 Type-2 Diabetes Population (2012-2025)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon

      11. 7.1.11 Medisana

      12. 7.1.12 Trivida

      13. 7.1.13 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Blood Glucose Monitoring Market market is studied from 2018 - 2026.

The North America Blood Glucose Monitoring Market is growing at a CAGR of 8.66% over the next 5 years.

  • Dexcom
  • Johnson & Johnson
  • Medtronics
  • F. Hoffmann-La Roche AG
  • Abbott Diabetes Care

Are the major companies operating in North America Blood Glucose Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!